Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$9.81 - $15.4 $53.9 Million - $84.7 Million
-5,496,833 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $15 Million - $18.2 Million
1,238,647 Added 29.09%
5,496,833 $74.4 Million
Q3 2021

Nov 10, 2021

BUY
$13.25 - $15.13 $820,983 - $937,469
61,961 Added 1.48%
4,258,186 $57.7 Million
Q2 2021

Aug 13, 2021

BUY
$12.97 - $16.15 $1.11 Million - $1.38 Million
85,679 Added 2.08%
4,196,225 $60 Million
Q1 2021

May 13, 2021

BUY
$13.59 - $18.54 $1.97 Million - $2.69 Million
145,056 Added 3.66%
4,110,546 $57.4 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $56.7 Million - $74.3 Million
3,965,490 New
3,965,490 $74.3 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.